These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 2862931)
21. [Age-related characteristics of the effect of adrenomimetics and adrenoblockaders on the calcium and magnesium content of the rat myocardium]. Viktorov AP; Tkachuk VV Farmakol Toksikol; 1987; 50(1):41-4. PubMed ID: 3556551 [TBL] [Abstract][Full Text] [Related]
22. Effects of adrenergic drugs on ciliary epithelium. Deshpande VR; Chandorkar AG; Balsara JJ Indian J Physiol Pharmacol; 1970 Jul; 14(3):175-9. PubMed ID: 4400783 [No Abstract] [Full Text] [Related]
23. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit. Zeiders JL; Seidler FJ; Slotkin TA J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819 [TBL] [Abstract][Full Text] [Related]
24. [Pharmacological characterization of the new highly potent beta-adrenergic receptor blocker soquinolol]. Gries J; Unger L; Einig H; Friedrich L; Hofmann HP; Kreiskott H; Lehmann HD; von Philipsborn G; Wuppermann D; Zimmermann F Arzneimittelforschung; 1988 Sep; 38(9):1271-9. PubMed ID: 2906243 [TBL] [Abstract][Full Text] [Related]
25. Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol. Horinouchi T; Morishima S; Tanaka T; Suzuki F; Tanaka Y; Koike K; Miwa S; Muramatsu I Life Sci; 2007 Jul; 81(5):399-404. PubMed ID: 17628611 [TBL] [Abstract][Full Text] [Related]
26. [Molecular mechanisms of regulatory action of adrenergic receptor agonists on functional activity of adenylyl cyclase signaling system of the ciliates Dileptus anser and Tetrahymena pyriformis]. Shpakov AO; Derkach KV; Uspenskaia ZI; Shpakova EA; Kuznetsova LA; Plesneva SA; Pertseva MN Tsitologiia; 2004; 46(4):317-25. PubMed ID: 15346790 [TBL] [Abstract][Full Text] [Related]
27. Interaction of cholecystokinin (CCK-8) with agonist and antagonist of beta-adrenergic receptors in circulatory system of diabetic rats. Wiśniewska RJ; Wiśniewski K Pol J Pharmacol; 1996; 48(3):293-7. PubMed ID: 9112665 [TBL] [Abstract][Full Text] [Related]
28. Beta-adrenergic receptors in ciliary processes of the rabbit. Bromberg BB; Gregory DS; Sears ML Invest Ophthalmol Vis Sci; 1980 Feb; 19(2):203-7. PubMed ID: 6243269 [TBL] [Abstract][Full Text] [Related]
29. Differential recovery of beta adrenoreceptor antagonist and agonist high affinity binding sites in the guinea-pig lung after irreversible blockade. Nelson CA; Muther TF; Pitha J; Baker SP J Pharmacol Exp Ther; 1986 Jun; 237(3):830-6. PubMed ID: 2872326 [TBL] [Abstract][Full Text] [Related]
30. Effects of chronic application of propranolol on beta-adrenergic signal transduction in heart ventricles from myopathic BIO TO2 and control hamsters. Witte K; Schnecko A; Hauth D; Wirzius S; Lemmer B Br J Pharmacol; 1998 Nov; 125(5):1033-41. PubMed ID: 9846642 [TBL] [Abstract][Full Text] [Related]
31. [Effect of pH changes on the binding of agonists and antagonists to the adrenergic beta receptor]. Gende OA; Camilión de Hurtado MC; Cingolani HE Acta Physiol Pharmacol Latinoam; 1985; 35(2):205-16. PubMed ID: 2870603 [TBL] [Abstract][Full Text] [Related]
32. Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists. Hoyer D; Reynolds EE; Molinoff PB Mol Pharmacol; 1984 Mar; 25(2):209-18. PubMed ID: 6142414 [TBL] [Abstract][Full Text] [Related]
33. Spontaneous coupling of the beta-adrenergic receptor to Ns in mammalian cardiac membranes. Nerme V; Severne Y; Abrahamsson T; Vauquelin G Mol Pharmacol; 1986 Jul; 30(1):1-5. PubMed ID: 3014306 [TBL] [Abstract][Full Text] [Related]
34. Effect of Apafant on bronchial hyperresponsiveness and down-regulation of beta-adrenoceptors induced by endotoxin in guinea pigs. Sugimoto Y; Mihara T; Hayakawa T; Nakayama Y; Kishida H; Kamei C Arzneimittelforschung; 1997 Jul; 47(7):837-41. PubMed ID: 9272241 [TBL] [Abstract][Full Text] [Related]
35. External transport of beta-adrenergic binding sites in ischemic myocardium. Drímal J; Knezl V; Magna D; Strízová K Gen Physiol Biophys; 1987 Dec; 6(6):583-91. PubMed ID: 2895037 [TBL] [Abstract][Full Text] [Related]
36. Comparison between the activities of cationic amphiphilic drugs to affect phospholipid-membranes and to depress cardiac function. Girke S; Mohr K; Schrape S Biochem Pharmacol; 1989 Aug; 38(15):2487-96. PubMed ID: 2569304 [TBL] [Abstract][Full Text] [Related]
37. [Decomposition and resynthesis of myocardial glycogen after the administration of beta sympathomimetics]. Mráz M; Faltová E; Sedivý J; Gaier N Bratisl Lek Listy; 1986 Jan; 85(1):31-9. PubMed ID: 2869827 [No Abstract] [Full Text] [Related]
38. Pharmacologic characterization of beta blockers with special reference to the significance of nonspecific membrane effects. Imai S Am J Cardiol; 1991 Apr; 67(10):8B-12B. PubMed ID: 1673583 [TBL] [Abstract][Full Text] [Related]
39. Causes of acute cardiotoxic effects of beta-adrenergic antagonist overdose. Langemeijer JJ; de Wildt DJ; de Groot G; Sangster B Lancet; 1986 Aug; 2(8503):401. PubMed ID: 2874400 [No Abstract] [Full Text] [Related]
40. [On the characteristics of the modification of glycide metabolism by adrenomimetics]. HYNIE S; WENKE M; MUEHLBACHOVA E Arzneimittelforschung; 1961 Sep; 11():858-61. PubMed ID: 14450350 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]